Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896

Watchlist Manager
Zhejiang Shouxiangu Pharmaceutical Co Ltd Logo
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Watchlist
Price: 21.37 CNY -0.6%
Market Cap: 4.2B CNY
Have any thoughts about
Zhejiang Shouxiangu Pharmaceutical Co Ltd?
Write Note

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Accounts Payable
ÂĄ167.8m
CAGR 3-Years
7%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Accounts Payable
ÂĄ2.4B
CAGR 3-Years
10%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Accounts Payable
ÂĄ514.4m
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Accounts Payable
ÂĄ1.1B
CAGR 3-Years
24%
CAGR 5-Years
24%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Accounts Payable
ÂĄ426.6m
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Accounts Payable
ÂĄ257.6m
CAGR 3-Years
94%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Consumer products

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.

Intrinsic Value
33.69 CNY
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Accounts Payable?
Accounts Payable
167.8m CNY

Based on the financial report for Sep 30, 2024, Zhejiang Shouxiangu Pharmaceutical Co Ltd's Accounts Payable amounts to 167.8m CNY.

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
43%

Over the last year, the Accounts Payable growth was 44%. The average annual Accounts Payable growth rates for Zhejiang Shouxiangu Pharmaceutical Co Ltd have been 7% over the past three years , 43% over the past five years .

Back to Top